More than 15 million people suffer from Atopic dermatitis. The rashes, redness, swelling, crusting and scaling of the skin caused by this condition can lead to severe trauma. It can strike anyone and even infants are not spared. Therefore it is a relief that SkinMedica, Inc. has developed Desonate Gel 0.05% for the treatment of mild-to-moderate atopic dermatitis. This product will be jointly promoted by SkinMedica and Galderma Laboratories. The benefits of this product were unveiled at the 65th Annual Meeting of the American Academy of Dermatology in Washington, on February 2-6, 2007.

Product Benefits
a. It is useful in the treatment of mild-to-moderate atopic dermatitis.
b. It is a low-potency topical steroid based on Dow's water-based Hydrogel vehicle.
c. The FDA has approved it for the treatment of atopic dermatitis in pediatric patients.
d. It can be used on both pediatric and adult patients.
e. It is the first and only treatment for atopic dermatitis formulated with patented Hydrogel Technology.
f. It can be used on hair-bearing and non-hair-bearing skin.
g. This gel does not contain alcohol, fragrance or any surfactants.
h. The Hydrogel molecule provides therapy in a cosmetically acceptable, non-drying delivery system.
i. Clinical trials have shown that this product is safe and effective.